MSNBC’s Jake Traylor reported via X: “EXCLUSIVE: Pharma company ‘AstraZeneca (AZN)’ strikes deal with White House to lower drug prices. Trump at 5pm today will announce an agreement with pharma company AstraZeneca aimed at making prescriptions more affordable for low-income Americans, according to a White House official. The deal also includes a $50 billion commitment from AstraZeneca to invest in drug manufacturing and research and development in the United States.” Shares of AstraZeneca are up 1%, or 72c, to $85.76 in midday trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca’s New Trial Targets Sepsis-Related Kidney Injury
- AstraZeneca Launches New Study on NSCLC Treatment Patterns
- AstraZeneca’s New Study Targets Improved Treatment for Elderly LBCL Patients
- AstraZeneca’s OPTIMISE-CKD Study: Insights into Chronic Kidney Disease Management
- AstraZeneca’s Latest Study on AZD5004: Key Insights for Investors